Bruce J. Brew

Active 1988–2025

156
Papers
25,014
Citations
91
h-index
152
i10-index

Citations

Citations per year for Bruce J. Brew1987: 10 citations1988: 20 citations1989: 23 citations1990: 34 citations1991: 41 citations1992: 71 citations1993: 75 citations1994: 42 citations1995: 44 citations1996: 45 citations1997: 57 citations1998: 73 citations1999: 79 citations2000: 38 citations2001: 96 citations2002: 74 citations2003: 91 citations2004: 114 citations2005: 164 citations2006: 118 citations2007: 122 citations2008: 141 citations2009: 219 citations2010: 212 citations2011: 213 citations2012: 211 citations2013: 212 citations2014: 253 citations2015: 232 citations2016: 258 citations2017: 190 citations2018: 166 citations2019: 684 citations2020: 680 citations2021: 646 citations2022: 496 citations2023: 444 citations2024: 1,020 citations2025: 640 citations2026: 22 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,752 citing papers, 31.1% of this breakdownUnited Kingdom: 649 citing papers, 7.3% of this breakdownAustralia: 582 citing papers, 6.6% of this breakdownChina: 552 citing papers, 6.2% of this breakdownGermany: 359 citing papers, 4.1% of this breakdownItaly: 321 citing papers, 3.6% of this breakdownFrance: 296 citing papers, 3.3% of this breakdownSweden: 295 citing papers, 3.3% of this breakdownCanada: 289 citing papers, 3.3% of this breakdownNetherlands: 212 citing papers, 2.4% of this breakdownSpain: 193 citing papers, 2.2% of this breakdownJapan: 177 citing papers, 2% of this breakdown
0%31.1%Other 24.6%

Fields

  • Medicine40.9%
  • Neuroscience24.6%
  • Immunology and Microbiology23.3%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Psychology0.7%
  • Computer Science0.6%
  • Other2.8%

Topics

  • HIV Research and Treatment8.3%
  • Tryptophan and brain disorders7.8%
  • Alzheimer's disease research and treatments5.8%
  • Neuroinflammation and Neurodegeneration Mechanisms5.3%
  • Dementia and Cognitive Impairment Research4%
  • Stress Responses and Cortisol3.4%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Donanemab in Early Symptomatic Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajaček, Dávid Barton, David G. Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra E. Black, Allan Block, Mohammad Reza Bolouri, Wendy Bond, Jean Bouthillier, Sharon A. Brangman, Bruce J. Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared R. Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey M. Burns, A Cabrera, Horace Capote, Ángel Carrasco, José Yépez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-Paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel M. Cohen, Robert M. Cohen, Ian J. Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P. L. J. Dautzenberg, Peter Paul De Deyn, Jose De La Gandara, Kenneth Deck, David DiBenedetto, Mark DiBuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John P. Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti and 209 more - JAMA 2023 cited by 2,562

  2. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

    Authors: , , , , , , , - Neuropharmacology 2016 cited by 381

  3. Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex

    Authors: , , , , , , - Archives of Clinical Neuropsychology 2009 cited by 639

  4. Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

    Authors: , , , - Glia 2004 cited by 482

  5. Deferiprone in Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2024 cited by 74

  6. Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau

    Authors: , , , , , , , , - Neurobiology of Aging 2019 cited by 130

  7. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

    Authors: , , , , , , , , - Scientific Reports 2017 cited by 261

  8. Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus

    Authors: , , , , - Neuropathology and Applied Neurobiology 2005 cited by 326

  9. Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons

    Authors: , , , , - Neurotoxicity Research 2009 cited by 226

  10. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

    Authors: , , , , , , , - Journal of Neurochemistry 2001 cited by 535

  11. Recent advances in clinical trials targeting the kynurenine pathway

    Authors: , , , , , - Pharmacology & Therapeutics 2021 cited by 87

  12. The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

    Authors: , , , , , - PLoS ONE 2009 cited by 247

  13. Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain

    Authors: , , , , , , , , , - PLoS ONE 2013 cited by 213

  14. Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Neurology 2022 cited by 79

  15. The kynurenine pathway relates to post‐acuteCOVID‐19 objective cognitive impairment andPASC

    Authors: , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2023 cited by 46

  16. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Andrew Josephson, Joseph L. DeRisi - JAMA Neurology 2018 cited by 313

  17. Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)

    Authors: , , , , , , , - PLoS ONE 2011 cited by 229

  18. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease

    Authors: , - Redox Report 2002 cited by 206

  19. Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials

    Authors: , , , , , - American Journal of Clinical Nutrition 2018 cited by 173

  20. Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology

    Authors: , , , , , , , , , - PLoS ONE 2014 cited by 153

  21. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes

    Authors: , , , , - Glia 2003 cited by 170

  22. Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease

    Authors: , , , , , , , , - PLoS ONE 2015 cited by 141

  23. Aβ1-42 induces production of quinolinic acid by human macrophages and microglia

    Authors: , , , , - Neuroreport 2003 cited by 137

  24. The Kynurenine Pathway in Brain Tumor Pathogenesis

    Authors: , , , , , , - Cancer Research 2012 cited by 150